VAGELOS P ROY 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Mar 27, 2023
Insider Transaction Report
Form 4
VAGELOS P ROY
Director
Transactions
- Gift
Common Stock
2023-03-23−25,000→ 312,578 total
Holdings
- 125,752(indirect: by CLAT)
Common Stock
- 3,609(indirect: By Trust)
Common Stock
- 1,963(indirect: By 401(k))
Common Stock
- 23,461(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 21, 2022.
- [F2]By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.